Illumina (ILMN) Said to Have Purchase Moleculo, Inc.

Illumina, Inc. (NASDAQ: ILMN) said it purchase Moleculo, Inc. The news comes as it filed an 8-K earlier disclosing that it withdrew its offer for Complete Genomics (Nasdaq: GNOM).

The biotech is presenting at the JPMorgan Global Healthcare Conference today. Shares are up 1.8 percent on the session.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Illumina (ILMN) PT Lowered to $125 at Baird
• Jana, in Letter, Urges Wolfspeed (WOLF) to Eye Sale, Other Strategic Alternatives - Reuters
• Salesforce abandons pursuit of Informatica - Reuters